Abstract
Biocompatible materials to comprise a $3.7 billion US market in 2010
US demand for biocompatible materials will increase 6.6 percent annually to
$3.7 billion in 2010. Gains will match the overall upward pace of end-use
product shipments as stricter FDA pre-market approval and production standards
mandate the upgrading of materials used in medical and dental implants and
drug delivery systems. Due to quality, performance and versatility advantages,
synthetic and natural polymers will continue to dominate the overall market
for biocompatible materials. However, metals and ceramics will continue to
build niche opportunities in specialty devices and equipment such as
orthopedic and dental implants, pacemaker and defibrillator components, and
stents.
View Cart
